Coherus Oncology, Inc. (CHRS)
Coherus Oncology Market Cap : 251.82M for April 10, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Johnson & Johnson | 574.36B |
| Stereotaxis, Inc. | 181.86M |
| Allogene Therapeutics, Inc. | 663.08M |
| Inovio Pharmaceuticals, Inc. | 73.24M |
| Nektar Therapeutics | 1.341B |
Market Cap Related Metrics
| PS Ratio | 4.666 |
| PEG Ratio | -0.0928 |
| Price to Book Value | 4.127 |
| Price | 1.68 |
| Earnings Yield | -86.68% |
| PEGY Ratio | -0.0928 |